← Every applicant
Hangzhou Zhongmei FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CASPOFUNGIN ACETATENew drugJul 18, 2025POWDER, INTRAVENOUS |
| FONDAPARINUX SODIUMNew drugAug 19, 2024SOLUTION, SUBCUTANEOUS |
| TACROLIMUSNew drugApr 17, 2023CAPSULE, ORAL |
| DAPTOMYCINNew drugNov 26, 2021POWDER, INTRAVENOUS |
| PANTOPRAZOLE SODIUMNew drugAug 30, 2021INJECTABLE, INTRAVENOUS |